These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 9616488)

  • 1. Cell and molecular mechanisms of pathogenesis and treatment of cancer.
    Rew DA
    Postgrad Med J; 1998 Feb; 74(868):77-88. PubMed ID: 9616488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity, biodiversity and bioperversity in solid neoplasms.
    Rew DA
    Eur J Surg Oncol; 1996 Oct; 22(5):469-73. PubMed ID: 8903487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumour-microenvironmental interactions: paths to progression and targets for treatment.
    Box C; Rogers SJ; Mendiola M; Eccles SA
    Semin Cancer Biol; 2010 Jun; 20(3):128-38. PubMed ID: 20599506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overview of resistance to systemic therapy in patients with breast cancer.
    Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
    Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanisms of drug resistance.
    Longley DB; Johnston PG
    J Pathol; 2005 Jan; 205(2):275-92. PubMed ID: 15641020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Range Expansion Theories Could Shed Light on the Spatial Structure of Intra-tumour Heterogeneity.
    Gidoin C; Peischl S
    Bull Math Biol; 2019 Nov; 81(11):4761-4777. PubMed ID: 30535848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spatial and temporal cancer evolution: causes and consequences of tumour diversity.
    Hiley CT; Swanton C
    Clin Med (Lond); 2014 Dec; 14 Suppl 6():s33-7. PubMed ID: 25468916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis of metastatic disease: implications for current therapy and for the development of new therapeutic strategies.
    Poste G
    Cancer Treat Rep; 1986 Jan; 70(1):183-99. PubMed ID: 3510734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel charged trinuclear platinum complex effective against cisplatin-resistant tumours: hypersensitivity of p53-mutant human tumour xenografts.
    Pratesi G; Perego P; Polizzi D; Righetti SC; Supino R; Caserini C; Manzotti C; Giuliani FC; Pezzoni G; Tognella S; Spinelli S; Farrell N; Zunino F
    Br J Cancer; 1999 Aug; 80(12):1912-9. PubMed ID: 10471039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of drug resistance in cancer chemotherapy.
    Luqmani YA
    Med Princ Pract; 2005; 14 Suppl 1():35-48. PubMed ID: 16103712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanisms of therapy resistance in solid tumors: chasing "moving" targets.
    Tafe LJ
    Virchows Arch; 2017 Aug; 471(2):155-164. PubMed ID: 28280929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Advances in research on the molecular pathogenesis of the malignant tumours and implications for their early diagnosis and treatment].
    Steffen J
    Med Wieku Rozwoj; 2000; 4(2 Suppl 2):11-25. PubMed ID: 11178325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumour heterogeneity and drug resistance: personalising cancer medicine through functional genomics.
    Lee AJ; Swanton C
    Biochem Pharmacol; 2012 Apr; 83(8):1013-20. PubMed ID: 22192819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stem cells in the etiology and treatment of cancer.
    Zhang M; Rosen JM
    Curr Opin Genet Dev; 2006 Feb; 16(1):60-4. PubMed ID: 16377171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cell cycle and carcinogenesis].
    Solé Balcells F
    Ann Urol (Paris); 1995; 29(5):271-9. PubMed ID: 8638907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new model for oncogenesis. From tumour immunology to a mathematical approach of oncogenesis.
    Den Otter W; Koten JW; Derkinderen DJ
    Anticancer Res; 1986; 6(3 Pt B):509-14. PubMed ID: 3740800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Italian cancer figures, report 2012: Cancer in children and adolescents.
    ; ;
    Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy curable malignancies and cancer stem cells: a biological review and hypothesis.
    Savage P
    BMC Cancer; 2016 Nov; 16(1):906. PubMed ID: 27871274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted therapies of solid cancers: new options, new challenges.
    Awada A; Aftimos PG
    Curr Opin Oncol; 2013 May; 25(3):296-304. PubMed ID: 23493191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High levels of X-linked Inhibitor-of-Apoptosis Protein (XIAP) are indicative of radio chemotherapy resistance in rectal cancer.
    Flanagan L; Kehoe J; Fay J; Bacon O; Lindner AU; Kay EW; Deasy J; McNamara DA; Prehn JH
    Radiat Oncol; 2015 Jun; 10():131. PubMed ID: 26071313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.